Inovio Pharmaceuticals (INO) Competitors $2.37 -0.09 (-3.66%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.36 -0.01 (-0.25%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INO vs. MRNA, DCTH, SNWV, BFLY, RXST, CLPT, SMTI, NPCE, TCMD, and BWAYShould you be buying Inovio Pharmaceuticals stock or one of its competitors? The main competitors of Inovio Pharmaceuticals include Moderna (MRNA), Delcath Systems (DCTH), Sanuwave Health (SNWV), Butterfly Network (BFLY), RxSight (RXST), ClearPoint Neuro (CLPT), Sanara MedTech (SMTI), NeuroPace (NPCE), Tactile Systems Technology (TCMD), and Brainsway (BWAY). These companies are all part of the "medical" sector. Inovio Pharmaceuticals vs. Its Competitors Moderna Delcath Systems Sanuwave Health Butterfly Network RxSight ClearPoint Neuro Sanara MedTech NeuroPace Tactile Systems Technology Brainsway Inovio Pharmaceuticals (NASDAQ:INO) and Moderna (NASDAQ:MRNA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment. Does the media refer more to INO or MRNA? In the previous week, Moderna had 13 more articles in the media than Inovio Pharmaceuticals. MarketBeat recorded 20 mentions for Moderna and 7 mentions for Inovio Pharmaceuticals. Moderna's average media sentiment score of 0.96 beat Inovio Pharmaceuticals' score of 0.84 indicating that Moderna is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inovio Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Moderna 10 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Do institutionals and insiders have more ownership in INO or MRNA? 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. Comparatively, 75.3% of Moderna shares are owned by institutional investors. 2.3% of Inovio Pharmaceuticals shares are owned by insiders. Comparatively, 11.0% of Moderna shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable earnings & valuation, INO or MRNA? Inovio Pharmaceuticals has higher earnings, but lower revenue than Moderna. Moderna is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInovio Pharmaceuticals$220K572.46-$107.25M-$2.61-0.91Moderna$3.24B2.90-$3.56B-$7.53-3.20 Which has more volatility and risk, INO or MRNA? Inovio Pharmaceuticals has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500. Comparatively, Moderna has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Do analysts prefer INO or MRNA? Inovio Pharmaceuticals currently has a consensus target price of $8.80, indicating a potential upside of 271.31%. Moderna has a consensus target price of $42.88, indicating a potential upside of 78.01%. Given Inovio Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Inovio Pharmaceuticals is more favorable than Moderna.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Moderna 4 Sell rating(s) 16 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.04 Is INO or MRNA more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to Moderna's net margin of -94.31%. Moderna's return on equity of -25.96% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Inovio PharmaceuticalsN/A -163.32% -96.41% Moderna -94.31%-25.96%-20.09% SummaryModerna beats Inovio Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INO vs. The Competition Export to ExcelMetricInovio PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$125.95M$3.07B$5.75B$9.76BDividend YieldN/A2.29%4.10%4.04%P/E Ratio-0.9120.7883.2726.59Price / Sales572.46386.79535.03111.31Price / CashN/A44.2237.4459.26Price / Book4.398.0710.556.58Net Income-$107.25M-$53.98M$3.27B$265.95M7 Day Performance20.92%-0.88%0.40%0.17%1 Month Performance66.90%7.72%7.31%3.90%1 Year Performance-67.17%7.03%46.58%19.67% Inovio Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INOInovio Pharmaceuticals4.011 of 5 stars$2.37-3.7%$8.80+271.3%-67.2%$125.95M$220K-0.91320News CoverageMRNAModerna4.514 of 5 stars$25.35-6.5%$42.88+69.2%-68.9%$10.55B$3.24B-3.375,800DCTHDelcath Systems3.1201 of 5 stars$10.89-2.1%$24.50+125.0%+0.2%$388.99M$37.21M217.8060News CoveragePositive NewsSNWVSanuwave Health2.2503 of 5 stars$42.66-5.2%$55.00+28.9%N/A$385.56M$32.63M-5.1740News CoverageAnalyst UpgradeBFLYButterfly Network3.2711 of 5 stars$1.56+2.3%$3.00+92.9%+48.8%$382.65M$82.06M-5.55460News CoveragePositive NewsRXSTRxSight1.569 of 5 stars$8.61-7.2%$10.00+16.1%-84.0%$379.70M$139.93M-10.76220Trending NewsCLPTClearPoint Neuro2.0487 of 5 stars$10.50-1.9%$19.67+87.3%-19.2%$304.17M$31.39M-12.96110Positive NewsSMTISanara MedTech1.7669 of 5 stars$32.93-3.0%$50.00+51.8%-6.2%$302.23M$86.67M-28.3960NPCENeuroPace3.1516 of 5 stars$8.65-3.8%$16.60+91.9%+15.5%$297.40M$79.91M-10.30170News CoverageTCMDTactile Systems Technology2.4235 of 5 stars$13.00-1.7%$13.50+3.8%-2.8%$294.92M$292.98M20.971,037Positive NewsBWAYBrainsway3.6397 of 5 stars$15.36+1.1%$18.00+17.2%+96.7%$287.31M$41.02M59.08120 Related Companies and Tools Related Companies Moderna Alternatives Delcath Systems Alternatives Sanuwave Health Alternatives Butterfly Network Alternatives RxSight Alternatives ClearPoint Neuro Alternatives Sanara MedTech Alternatives NeuroPace Alternatives Tactile Systems Technology Alternatives Brainsway Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INO) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INO Stock Alerts